Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

21.78 USD +0.46 (+2.16%)
Official Closing Price Updated: 5:39 PM EST, Dec 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Acadia Pharmaceutica

< Previous 1 2 3 4 5 6 7 8 9 Next >
Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?
All of these names are down for a reason, but only some of them are down for a reason that's apt to last. 
Tags Market News LFST IQ
From Motley Fool
Good Stocks To Invest In Right Now? 4 Health Care Stocks To Check Out
Tags Market News
From StockMarket.com
What 7 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
Over the past 3 months, 7 analysts have published their opinion on ACADIA Pharmaceuticals (NASDAQ:ACAD) stock. These analysts are ... 
Tags Analyst Ratings Market News ACAD
From Benzinga
LABU, ALXO, ACAD, AGEN: Large Inflows Detected at ETF
Symbols mentioned in this story: LABU, ALXO, ACAD, AGEN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Why Acadia Pharmaceuticals Stock Is Rocketing Today
A positive clinical readout is lighting a fire underneath the biotech's shares today. 
Tags ACAD Recent Press Releases Market News
From Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive ... 
Tags MGTX GSK DARE
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The ... 
Tags Top Gainers Markets CPIX
From Benzinga
10 Biggest Price Target Changes For Tuesday
Oppenheimer cut the price target on Coupa Software Incorporated (NASDAQ: COUP) from $275 to $225. Coupa Software shares fell 12.6% ... 
Tags COUP Price Target Analyst Ratings
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're beginning another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! The... 
Tags ACAD HYMC AHI
From InvestorPlace
22 Stocks Moving in Tuesday's Pre-Market Session
Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) rose 23.7% to $3.18 in pre-market trading after jumping 10% on Monday. The ... 
Tags VAXX MOXC MDB
From Benzinga
Acadia Pharma Jumps After Rett Syndrome Candidate Aces Phase 3 Study
Acadia Pharmaceuticals Inc(NASDAQ: ACAD)announced topline resultsfrom Phase 3 Lavender study of trofinetide in ... 
Tags Market News Health Care Rett Syndrome
From Benzinga
Acadia Pharmaceuticals Stock Sprints After Rett Syndrome Drug Scores A Testing Win
Acadia Pharmaceuticals said late Monday its Rett syndrome treatment succeeded in a pivotal study — and ACAD stock rocketed. 
From Investor's Business Daily
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 24.26% to $24.11 during Monday's after-market session. Today's trading volume ... 
Tags APTX HQY OCUP
From Benzinga
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced positive top-line results from the pivotal, Phase 3 Lavender™ study evaluating the efficacy and safety of trofinetide in 187 girls and young... 
From Business Wire News Releases
First Week of June 2022 Options Trading For Acadia Pharmaceuticals (ACAD)
Investors in Acadia Pharmaceuticals Inc (ACAD) saw new options begin trading this week, for the June 2022 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Symptoms of Schizophrenia
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that The Lancet Psychiatry published results from the Phase 2 ADVANCE study. ADVANCE was an international, 26-week, randomized, double-blind,... 
From Business Wire News Releases
Noteworthy ETF Inflows: LABU, ALXO, ABBV, ACAD
Symbols mentioned in this story: LABU, ALXO, ABBV, ACAD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Notable ETF Inflow Detected - LABU, ALXO, ABBV, ACAD
Symbols mentioned in this story: LABU, ALXO, ABBV, ACAD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campaign to Bring Greater Awareness to Parkinson’s Disease Non-Motor Symptoms
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the national launch of Yours, Truly, a multicultural, storytelling campaign to bring greater awareness and understanding of the varied... 
From Business Wire News Releases
December 31st Options Now Available For Acadia Pharmaceuticals
Investors in Acadia Pharmaceuticals Inc (ACAD) saw new options begin trading today, for the December 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACAD... 
Tags Stocks
From Market News Video
LABU, ALXO, ABBV, ACAD: Large Outflows Detected at ETF
Symbols mentioned in this story: LABU, ALXO, ABBV, ACAD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Frequency Therapeutics (NASDAQ:FREQ) stock rose 10.94% to $7.51 during Tuesday's regular session. The ... 
Tags BZI/TFM Intraday Update STTK
From Benzinga
Acadia Pharmaceuticals Inc (ACAD) Q3 2021 Earnings Call Transcript
ACAD earnings call for the period ending November 8, 2021. 
Tags Market News Recent Press Releases ACAD
From Motley Fool
ACADIA Pharmaceuticals: Q3 Earnings Insights
ACADIA Pharmaceuticals (NASDAQ:ACAD) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM. Here's what ... 
Tags BZI/Recaps ACAD Earnings
From Benzinga
Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the third quarter ended September 30, 2021. 
From Business Wire News Releases
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good ... 
Tags LGND ACIU CCXI
From Benzinga
Acadia Pharmaceuticals Presents New Dementia-Related Psychosis Real-World Outcomes Data at Psych Congress 2021
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that three data presentations featuring new analyses of Medicare claims data on dementia-related psychosis (DRP) outcomes were presented at... 
From Business Wire News Releases
Acadia Pharmaceuticals Appoints Brendan Teehan, Executive Vice President, Chief Operating Officer, Head of Commercial
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the promotion of Brendan Teehan to Executive Vice President, Chief Operating Officer, Head of Commercial, effective immediately. Mr. Teehan,... 
From Business Wire News Releases
Where ACADIA Pharmaceuticals Stands With Analysts
Over the past 3 months, 5 analysts have published their opinion on ACADIA Pharmaceuticals (NASDAQ:ACAD) stock. These analysts are ... 
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
ACAD December 10th Options Begin Trading
Investors in Acadia Pharmaceuticals Inc (ACAD) saw new options become available today, for the December 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACAD... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.